| scholarly article | Q13442814 |
| P356 | DOI | 10.1038/NG.3471 |
| P2888 | exact match | https://scigraph.springernature.com/pub.10.1038/ng.3471 |
| P932 | PMC publication ID | 4731297 |
| P698 | PubMed publication ID | 26691984 |
| P50 | author | Can Cenik | Q38305140 |
| Carlos L Araya | Q40068060 | ||
| William Greenleaf | Q59751359 | ||
| P2093 | author name string | Vijay S Pande | |
| Michael P Snyder | |||
| Jason A Reuter | |||
| Gert Kiss | |||
| P2860 | cites work | Genome analysis reveals interplay between 5'UTR introns and nuclear mRNA export for secretory and mitochondrial genes | Q21092427 |
| An integrated encyclopedia of DNA elements in the human genome | Q22122150 | ||
| Identification of a tissue-specific putative transcription factor in breast tissue by serological screening of a breast cancer library | Q24291069 | ||
| Structure of the BRAF-MEK complex reveals a kinase activity independent role for BRAF in MAPK signaling | Q24302450 | ||
| The RAB25 small GTPase determines aggressiveness of ovarian and breast cancers | Q24308778 | ||
| A landscape of driver mutations in melanoma | Q24603357 | ||
| Mutational heterogeneity in cancer and the search for new cancer-associated genes | Q24606956 | ||
| Exome sequencing identifies recurrent SPOP, FOXA1 and MED12 mutations in prostate cancer | Q24616117 | ||
| PhosphoSitePlus: a comprehensive resource for investigating the structure and function of experimentally determined post-translational modifications in man and mouse | Q24619841 | ||
| Biopython: freely available Python tools for computational molecular biology and bioinformatics | Q24643426 | ||
| A census of human cancer genes | Q24647081 | ||
| An integrated genomic analysis of human glioblastoma multiforme | Q24648860 | ||
| Investigating the structure and dynamics of the PIK3CA wild-type and H1047R oncogenic mutant | Q27320874 | ||
| Mechanism of two classes of cancer mutations in the phosphoinositide 3-kinase catalytic subunit | Q27646654 | ||
| The structure of a human p110alpha/p85alpha complex elucidates the effects of oncogenic PI3Kalpha mutations | Q27649316 | ||
| Mutations of the BRAF gene in human cancer | Q27860760 | ||
| High frequency of mutations of the PIK3CA gene in human cancers | Q28131776 | ||
| Oncogene-induced Nrf2 transcription promotes ROS detoxification and tumorigenesis | Q28242612 | ||
| Lagging-strand replication shapes the mutational landscape of the genome | Q28255984 | ||
| SMAD2, SMAD3 and SMAD4 mutations in colorectal cancer | Q28278952 | ||
| Integrated genomic characterization of endometrial carcinoma | Q28289962 | ||
| Discovery and saturation analysis of cancer genes across 21 tumour types | Q28305204 | ||
| Human cancer protein-protein interaction network: a structural perspective | Q28472174 | ||
| Signatures of mutational processes in human cancer | Q29547191 | ||
| Highly recurrent TERT promoter mutations in human melanoma | Q29614798 | ||
| A program for annotating and predicting the effects of single nucleotide polymorphisms, SnpEff: SNPs in the genome of Drosophila melanogaster strain w1118; iso-2; iso-3 | Q29614852 | ||
| Integrative analysis of 111 reference human epigenomes | Q29615565 | ||
| Proteomics. Tissue-based map of the human proteome | Q29617248 | ||
| Breakpoint profiling of 64 cancer genomes reveals numerous complex rearrangements spawned by homology-independent mechanisms | Q30416550 | ||
| MuSiC: identifying mutational significance in cancer genomes | Q30418806 | ||
| Pybedtools: a flexible Python library for manipulating genomic datasets and annotations | Q30429349 | ||
| TCPA: a resource for cancer functional proteomics data | Q30666936 | ||
| Increased expression of genes converting adrenal androgens to testosterone in androgen-independent prostate cancer | Q33235187 | ||
| Studying tumorigenesis through network evolution and somatic mutational perturbations in the cancer interactome | Q33923533 | ||
| Conserved microRNA targeting in Drosophila is as widespread in coding regions as in 3'UTRs | Q34115739 | ||
| Expanding the computational toolbox for mining cancer genomes | Q34207474 | ||
| Activation of diverse signalling pathways by oncogenic PIK3CA mutations | Q34408364 | ||
| MiRmap: comprehensive prediction of microRNA target repression strength. | Q34433254 | ||
| Comparative analysis of regulatory information and circuits across distant species | Q34435561 | ||
| Pan-cancer network analysis identifies combinations of rare somatic mutations across pathways and protein complexes | Q34667055 | ||
| RNA G-quadruplexes cause eIF4A-dependent oncogene translation in cancer | Q35216351 | ||
| PI3K in cancer: divergent roles of isoforms, modes of activation and therapeutic targeting | Q35260766 | ||
| Cell-of-origin chromatin organization shapes the mutational landscape of cancer | Q35510462 | ||
| Recurrent somatic mutations in regulatory regions of human cancer genomes | Q35797838 | ||
| Oncogenic mutations mimic and enhance dynamic events in the natural activation of phosphoinositide 3-kinase p110α (PIK3CA). | Q36279889 | ||
| A fundamental protein property, thermodynamic stability, revealed solely from large-scale measurements of protein function | Q36342633 | ||
| Helical domain and kinase domain mutations in p110alpha of phosphatidylinositol 3-kinase induce gain of function by different mechanisms | Q36497469 | ||
| Small nucleolar RNA 42 acts as an oncogene in lung tumorigenesis | Q37138610 | ||
| An APOBEC cytidine deaminase mutagenesis pattern is widespread in human cancers | Q37211712 | ||
| Gene expression patterns unveil a new level of molecular heterogeneity in colorectal cancer | Q37343279 | ||
| Interaction-based discovery of functionally important genes in cancers | Q37574182 | ||
| Exonic transcription factor binding directs codon choice and affects protein evolution | Q37668081 | ||
| The DNA damage response and cancer therapy | Q37977004 | ||
| The p90 RSK family members: common functions and isoform specificity | Q38130898 | ||
| Histone H3.3 mutations: a variant path to cancer | Q38162525 | ||
| OncodriveCLUST: exploiting the positional clustering of somatic mutations to identify cancer genes | Q38453390 | ||
| Clinical significance of SNORA42 as an oncogene and a prognostic biomarker in colorectal cancer | Q38827252 | ||
| Differential DNA mismatch repair underlies mutation rate variation across the human genome | Q38906828 | ||
| Overexpression of Rab25 contributes to metastasis of bladder cancer through induction of epithelial-mesenchymal transition and activation of Akt/GSK-3β/Snail signaling. | Q39145571 | ||
| Conservation of trans-acting circuitry during mammalian regulatory evolution | Q39843784 | ||
| Quantitative analysis of RNA-protein interactions on a massively parallel array reveals biophysical and evolutionary landscapes | Q40067843 | ||
| Selective loss of AKR1C1 and AKR1C2 in breast cancer and their potential effect on progesterone signaling | Q40502570 | ||
| Genome-wide analysis of noncoding regulatory mutations in cancer | Q41842692 | ||
| e-Driver: a novel method to identify protein regions driving cancer | Q41985710 | ||
| A common cancer-associated DNA polymerase ε mutation causes an exceptionally strong mutator phenotype, indicating fidelity defects distinct from loss of proofreading | Q41990410 | ||
| Network-based stratification of tumor mutations | Q42034112 | ||
| Regulatory analysis of the C. elegans genome with spatiotemporal resolution | Q42429601 | ||
| RNA splicing. The human splicing code reveals new insights into the genetic determinants of disease | Q42558500 | ||
| Hidden specificity in an apparently nonspecific RNA-binding protein | Q42689235 | ||
| A census of amplified and overexpressed human cancer genes | Q44951771 | ||
| AKR1C1 and AKR1C3 may determine progesterone and estrogen ratios in endometrial cancer | Q46842961 | ||
| Systematic analysis of noncoding somatic mutations and gene expression alterations across 14 tumor types. | Q54310538 | ||
| Synonymous Mutations Frequently Act as Driver Mutations in Human Cancers | Q55554493 | ||
| Python for Scientists and Engineers | Q56532722 | ||
| Non-coding recurrent mutations in chronic lymphocytic leukaemia | Q56996904 | ||
| The NumPy Array: A Structure for Efficient Numerical Computation | Q57317251 | ||
| A census of human RNA-binding proteins | Q58283908 | ||
| Python for Scientific Computing | Q62058750 | ||
| P433 | issue | 2 | |
| P407 | language of work or name | English | Q1860 |
| P304 | page(s) | 117-125 | |
| P577 | publication date | 2015-12-21 | |
| P1433 | published in | Nature Genetics | Q976454 |
| P1476 | title | Identification of significantly mutated regions across cancer types highlights a rich landscape of functional molecular alterations | |
| P478 | volume | 48 |
| Q58718413 | A distinct class of antioxidant response elements is consistently activated in tumors with NRF2 mutations |
| Q41125698 | Analysis of somatic mutations across the kinome reveals loss-of-function mutations in multiple cancer types |
| Q36107701 | CLIC5: a novel ETV6 target gene in childhood acute lymphoblastic leukemia |
| Q89555513 | Combined burden and functional impact tests for cancer driver discovery using DriverPower |
| Q38675855 | Comparison of algorithms for the detection of cancer drivers at subgene resolution |
| Q49887410 | Comprehensive Analysis of Constraint on the Spatial Distribution of Missense Variants in Human Protein Structures. |
| Q58602209 | Criticality in tumor evolution and clinical outcome |
| Q46437135 | Cross-species analysis of the canine and human bladder cancer transcriptome and exome |
| Q52315593 | Dissecting the sources of gene expression variation in a pan-cancer analysis identifies novel regulatory mutations. |
| Q48262529 | Dominant-negative SMARCA4 mutants alter the accessibility landscape of tissue-unrestricted enhancers. |
| Q55495686 | ETS transcription factors induce a unique UV damage signature that drives recurrent mutagenesis in melanoma. |
| Q61454969 | Elevated pyrimidine dimer formation at distinct genomic bases underlies promoter mutation hotspots in UV-exposed cancers |
| Q36319724 | Epigenomic annotation of noncoding mutations identifies mutated pathways in primary liver cancer |
| Q64082404 | Finding driver mutations in cancer: Elucidating the role of background mutational processes |
| Q89288057 | Gene regulatory effects of disease-associated variation in the NRF2 network |
| Q36220868 | Genetic study of congenital bile-duct dilatation identifies de novo and inherited variants in functionally related genes |
| Q94584348 | HotSpotAnnotations-a database for hotspot mutations and annotations in cancer |
| Q49489514 | IW-Scoring: an Integrative Weighted Scoring framework for annotating and prioritizing genetic variations in the noncoding genome. |
| Q49721248 | Identification of Single Nucleotide Non-coding Driver Mutations in Cancer. |
| Q42319791 | Identification of outcome-related driver mutations in cancer using conditional co-occurrence distributions. |
| Q92127168 | In Silico Analysis of Gene Expression Change Associated with Copy Number of Enhancers in Pancreatic Adenocarcinoma |
| Q89983086 | Integrated structural and evolutionary analysis reveals common mechanisms underlying adaptive evolution in mammals |
| Q52373176 | Integrative omics for health and disease. |
| Q55209361 | Network-Based Predictors of Progression in Head and Neck Squamous Cell Carcinoma. |
| Q60311034 | Nucleosome positions establish an extended mutation signature in melanoma |
| Q37010993 | OncodriveFML: a general framework to identify coding and non-coding regions with cancer driver mutations |
| Q36343608 | Pan-cancer analysis of systematic batch effects on somatic sequence variations |
| Q90129973 | Passenger Hotspot Mutations in Cancer |
| Q60923306 | Personal Mutanomes Meet Modern Oncology Drug Discovery and Precision Health |
| Q100737123 | Prediction of genome-wide effects of single nucleotide variants on transcription factor binding |
| Q91884598 | Recurrent Noncoding Mutations in Skin Cancers: UV Damage Susceptibility or Repair Inhibition as Primary Driver? |
| Q50918699 | Recurrent and functional regulatory mutations in breast cancer. |
| Q40211104 | Recurrent noncoding regulatory mutations in pancreatic ductal adenocarcinoma |
| Q36367931 | Recurrent promoter mutations in melanoma are defined by an extended context-specific mutational signature |
| Q52639487 | Systematic characterization of pan-cancer mutation clusters. |
| Q38952751 | The pharmacogenomics of drug resistance to protein kinase inhibitors. |
| Q47556060 | lncRNA Gene Signatures for Prediction of Breast Cancer Intrinsic Subtypes and Prognosis |
Search more.